EUVIMEDEUVIMED entdecken
Crossref

Chitosan‐collagen‐fibrinogen uncrosslinked scaffolds possessing skin regeneration and vascularization potential

Shalini Dasgupta, Ayan Gope, Anurup Mukhopadhyay, Prashant Kumar, Jyotirmoy Chatterjee, Ananya Barui iD

Journal of Biomedical Materials Research Part A · 2023-05 · 111 (5) · 725-739

DOI: 10.1002/jbm.a.37488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 27.12.2022. Verfasst von Shalini Dasgupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, Howrah, India. Hauptthemen laut MEDLINE: Chitosan, Hemostatics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical success of regenerative medicine for treating deep‐tissue skin injuries depends on the availability of skin grafts. Though bioengineered constructs are tested clinically, lack of neovascularization provide only superficial healing. Thus constructs, which promotes wound healing and supports vascularization has gained priority in tissue engineering. In this study, chitosan‐collagen‐fibrinogen (CCF) scaffold was fabricated using freeze‐drying method without using any chemical crosslinkers. CCF scaffolds proved cytocompatibility and faster healing in in vitro scratch assay of primary human adult dermal fibroblasts cells with progressively increasing vascular endothelial growth factor‐A and reducing vascular endothelial growth factor receptor 1 expressions. Skin regeneration evaluated on in vivo full thickness wound model confirmed faster remodeling with angiogenic signatures in CCF scaffold‐implanted mice. Histopathological observations corroborated with stereo‐zoom and SS‐optical coherence tomography images of wound sites to prove the maturation of healing‐bed, after 12 days of CCF implantation. Therefore, it is concluded that CCF scaffolds are promising for skin tissue regeneration and demonstrates pro‐angiogenic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanHemostaticsHumansMiceAnimalsVascular Endothelial Growth Factor AFibrinogenTissue ScaffoldsSkinCollagenNeovascularization, Pathologic

Stichwörter der Autor:innen

chemically uncrosslinked scaffoldin vivo wound modelskin graftvascularizationwound healing

Substanzen

Vascular Endothelial Growth Factor AChitosanFibrinogenCollagenHemostatics

Autor:innen und Institutionen

  • Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, Howrah, India.
  • School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.

ORCID-Profile: Ananya Barui

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Dasgupta, S., Gope, A., Mukhopadhyay, A., Kumar, P., Chatterjee, J., & Barui, A. (2023). Chitosan‐collagen‐fibrinogen uncrosslinked scaffolds possessing skin regeneration and vascularization potential. Journal of Biomedical Materials Research Part A, 111(5), 725-739. https://doi.org/10.1002/jbm.a.37488

Vancouver

Dasgupta S, Gope A, Mukhopadhyay A, Kumar P, Chatterjee J, Barui A. Chitosan‐collagen‐fibrinogen uncrosslinked scaffolds possessing skin regeneration and vascularization potential. Journal of Biomedical Materials Research Part A. 2023;111(5):725-739. doi:10.1002/jbm.a.37488

BibTeX
@article{Dasgupta2023,
  author = {Dasgupta, Shalini and Gope, Ayan and Mukhopadhyay, Anurup and Kumar, Prashant and Chatterjee, Jyotirmoy and Barui, Ananya},
  title = {Chitosan‐collagen‐fibrinogen uncrosslinked scaffolds possessing skin regeneration and vascularization potential},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2023},
  volume = {111},
  number = {5},
  pages = {725--739},
  doi = {10.1002/jbm.a.37488}
}
Kostenlos starten →